Eyebright Net Receivables from 2010 to 2024
| 688050 Stock | 91.28 2.78 3.14% |
Net Receivables | First Reported 2010-12-31 | Previous Quarter 212.8 M | Current Value 113.7 M | Quarterly Volatility 41.5 M |
Check Eyebright Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eyebright Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 70.9 M, Interest Expense of 10.3 M or Selling General Administrative of 226.9 M, as well as many indicators such as . Eyebright financial statements analysis is a perfect complement when working with Eyebright Medical Valuation or Volatility modules.
Eyebright | Net Receivables |
Currently Active Assets on Macroaxis
Other Information on Investing in Eyebright Stock
Eyebright Medical financial ratios help investors to determine whether Eyebright Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eyebright with respect to the benefits of owning Eyebright Medical security.